AMLX vs EIX
Amylyx Pharmaceuticals Inc (AMLX) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
AMLX currently screens at market cap $561.6M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the AMLX and EIX stock pages for the full models.
Not investment advice.